Immunohistochemical Expression of HER2/neu Receptors in Iraqi Patients with Endometrioid CarcinomaCorrespondence Address :
Alaa Qasim Yahya,
Maghrib Street, Baghdad, Iraq.
Introduction: With the advent of era of targeted cancer therapy, the serious side effects of chemoradiotherapy have been minimised. Considering the success story of anti-HER2/neu drugs in breast cancer oncology, the present study was conducted. The study evaluates the immunohistochemical expression of HER2/neu in endometrioid cancer among Iraqi patients.
Aim: To assess the immunohistochemical expression of HER2/neu in endometrioid carcinoma of uterus and to find the relationship of this expression with FIGO stage and grade and with patient age.
Materials and Methods: In this cross sectional study, formalin-fixed, paraffin-embedded tissue blocks of 62 hysterectomy specimens that were diagnosed as endometrioid carcinoma in the teaching laboratories in the Medical City complex, Baghdad were retrieved and assessed by three pathologists using the same scoring system for HER2/neu as in breast cancer with positivity regarded as +2 or +3. Statistical correlation using Chi-square test analysis was done.
Results: Out of 62 cases of endometrioid carcinoma, 30 (48.38%) were positive for HER2/neu and a significant statistical relationship between expression of this marker with histological grade and patient age was seen. The cases which were immunohistochemically positive for HER2/neu were closely associated with high grade morphology and patients younger than 40-year-old.
Conclusion: Endometrioid carcinoma is a type of endometrial adenocarcinoma commonly having a well differentiated morphology (Grade I) and low stage at presentation. The study concludes that young patients with a high grade endometrioid carcinoma would hopefully benefit from the application of targeted anti-HER2/neu therapy in future.
Endometrioid carcinoma, Immunohistochemistry, Post menopausal
Zinah Hussein Abd Ali, Farah Falah Hassan, Alaa Qasim Yahya. IMMUNOHISTOCHEMICAL EXPRESSION OF HER2/NEU RECEPTORS IN IRAQI PATIENTS WITH ENDOMETRIOID CARCINOMA. Journal of Clinical and Diagnostic Research [serial online] 2018 November [cited: 2019 Jan 19 ]; 12:EC05-EC08. Available from
Date of Submission: May 26, 2018
Date of Peer Review: Jul 13, 2018
Date of Acceptance: Jul 25, 2018
Date of Publishing: Nov 01, 2018
FINANCIAL OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters),
- Index Copernicus ICV 2016: 132.37,
- Academic Search Complete Database,
- Directory of Open Access Journals (DOAJ),
- Embase & EMbiology ,
- Google Scholar,
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA),
- Journal seek Database,
- Popline (reproductive health literature),